Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04878120 · ClinicalTrials.gov registry record · NA

Hybrid Closed-Loop Control With Smart Prandial Insulin Dosing in Type 1 Diabetes

A NA study, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
25
Enrollment target

NCT04878120 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 25 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04878120, a NA study, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

The objective of this study is to evaluate the safety and feasibility of a smart bolus calculator that adjusts insulin dosing for meals according to real-time insulin sensitivity (SI) in adolescents with type 1 diabetes (T1D) using a hybrid closed loop (HCL) system during an active week of diabetes camp.

Interventions

  • DEVICE Standard HCL System
  • DEVICE HCL System with Smart Bolus Calculator

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2021-05-14
Est. Completion 2022-06-28
Phase NA

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT04878120

The ClinicalTrials.gov registry entry for NCT04878120 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Standard HCL System is the first listed.

NCT04878120 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04878120 about?

NCT04878120 is a clinical study titled "Hybrid Closed-Loop Control With Smart Prandial Insulin Dosing in Type 1 Diabetes". The objective of this study is to evaluate the safety and feasibility of a smart bolus calculator that adjusts insulin dosing for meals according to real-time insulin sensitivity (SI) in adolescents with type 1 diabetes (T1D) using a hybrid closed loop (HCL) system during an active week of diabetes ...

What is the current status of trial NCT04878120?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2021-05-14. Estimated completion is 2022-06-28.

What interventions are being tested in trial NCT04878120?

The interventions under investigation include: Standard HCL System (DEVICE), HCL System with Smart Bolus Calculator (DEVICE).

Who is sponsoring clinical trial NCT04878120?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.